These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9185711)

  • 1. In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines.
    Nuovo GJ
    Int J Cancer; 1997 Jun; 71(6):1056-60. PubMed ID: 9185711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix.
    Davidson B; Goldberg I; Liokumovich P; Kopolovic J; Gotlieb WH; Lerner-Geva L; Reder I; Ben-Baruch G; Reich R
    Int J Gynecol Pathol; 1998 Oct; 17(4):295-301. PubMed ID: 9785129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
    Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL
    Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
    Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
    Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
    Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
    Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.
    da Silva Cardeal LB; Brohem CA; Corrêa TC; Winnischofer SM; Nakano F; Boccardo E; Villa LL; Sogayar MC; Maria-Engler SS
    Biochem Cell Biol; 2006 Oct; 84(5):713-9. PubMed ID: 17167534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
    Onisto M; Garbisa S; Caenazzo C; Freda MP; Di Francesco C; Nitti D; Liotta LA; Stetler-Stevenson WG
    Diagn Mol Pathol; 1993 Jun; 2(2):74-80. PubMed ID: 8269280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
    Wang M; Fudge K; Rhim JS; Stearns ME
    Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion.
    Zhai Y; Hotary KB; Nan B; Bosch FX; Muñoz N; Weiss SJ; Cho KR
    Cancer Res; 2005 Aug; 65(15):6543-50. PubMed ID: 16061633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R; Hinz B
    J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.
    Monvoisin A; Bisson C; Si-Tayeb K; Balabaud C; Desmoulière A; Rosenbaum J
    Int J Cancer; 2002 Jan; 97(2):157-62. PubMed ID: 11774258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
    Polette M; Clavel C; Birembaut P; De Clerck YA
    Pathol Res Pract; 1993 Nov; 189(9):1052-7. PubMed ID: 8302724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
    J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression.
    Sun L; Diamond ME; Ottaviano AJ; Joseph MJ; Ananthanarayan V; Munshi HG
    Mol Cancer Res; 2008 Jan; 6(1):10-20. PubMed ID: 18234959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R; Eichele K; Hinz B
    Oncogene; 2007 Aug; 26(39):5822-7. PubMed ID: 17369856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors.
    Murashige M; Miyahara M; Shiraishi N; Saito T; Kohno K; Kobayashi M
    Jpn J Clin Oncol; 1996 Oct; 26(5):303-9. PubMed ID: 8895669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
    Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
    Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.